KALB MICHAEL WAYNE (EVP & Chief Financial Officer) reported 1 transaction at CINCOR PHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/24/2023ACC: 0001209191-23-012895
Officer· EVP & Chief Financial Officer
Since Nov 2022
-280.05K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
280.05K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−202.44K
Price / share
—
Trade value
—
% of position
New position
2/24/2023
202.44K→0.00
Total
Net shares
−202.44K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2023 | D · Disposition | −202.44K | — | — | New position | 202.44K | 0.00 |
| Total | −202.44K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
77.61K shares
Shares
−77.61K
Strike price
30.07
Held after
0.00
Exercisable
—
2/24/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock77.61K shares | 2/24/2023 | D · Disposition | −77.61K | 30.07 | — | 0.00 |